|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUES: | |||||
| Gross written premiums | |||||
| Ceded written premiums | |||||
| Net written premiums | |||||
| Net change in unearned premiums | |||||
| Net premiums earned | |||||
| Investment income | |||||
| Net realized gain on investments | |||||
| Net unrealized gain on investments | |||||
| Change in fair value of derivative financial liabilities | |||||
| Change in allowance for expected credit losses on investments | |||||
| Other revenues | |||||
| Total revenues | |||||
| EXPENSES: | |||||
| Net loss and loss adjustment expenses | |||||
| Net policy acquisition expenses | |||||
| General and administrative expenses | |||||
| Change in allowance for expected credit losses on receivables | |||||
| Change in fair value of derivative financial liabilities | |||||
| Other expenses | |||||
| Net foreign exchange gain (loss) | |||||
| Total expenses | |||||
| Total expenses | |||||
| Income before income taxes | |||||
| Income tax credit (expense) | |||||
| Net Income | |||||
| Earnings Per Share | |||||
| Basic earnings per share attributable to equity holders (in USD per share) | |||||
| Diluted earnings per share attributable to equity holders (in Dollars per share) | |||||
Loading...